Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Letter To Editor

Multigenic traits and risk assessment in pharmacology: a population approach

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Nebert DW, Menon AG . The Pharmacogenomics Journal 2001 1: 19–22

  2. Kalow W, Bertilsson L . Advanc Drug Res 1994 23: 1–53

  3. Kalow W . Arch Pathol Lab Med 2000 125: 77–80

  4. Kalow W . Drug Metab Disp 2001 29: 468–470

Download references

Acknowledgements

We thank Dr Laszlo Endrenyi for helpful discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W Kalow.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalow, W., Ozdemir, V. & Tothfalusi, L. Multigenic traits and risk assessment in pharmacology: a population approach. Pharmacogenomics J 1, 234–235 (2001). https://doi.org/10.1038/sj.tpj.6500061

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500061

This article is cited by

Search

Quick links